Loading...
Symbols:
Loading...
Symbols:
Biotech HOLDRs (BBH)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Biotech HOLDRs (BBH)
61 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on BBH
- Nick Perry(14)
- TickerSense (6)
- Bespoke Investment Group(5)
- Tom Lydon(4)
- Roger Nusbaum(3)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(576)
- Trader Mark(492)
- Andrew Wilkinson(334)
- Roger Nusbaum(325)
- Richard Shaw(238)
Most commented on authors
- Ohad Hammer(13)
- Nick Perry(11)
- Option Dragon(10)
- SA Editors(8)
- Bespoke Investment Group(7)
- Winning and Losing Sectors for the Obama Administration
- Healthcare ETFs Are Outpacing the Market
- Recessionary Equity Strategies: Choosing Defensive Businesses
- 'When There's Blood in the Streets', Buy Biotech Stocks
- Biotech ETFs: Can You Handle 209% Volatility?
- Three Biotech ETFs: A Way To Follow the 'Smart Money' into Healthcare
- ETFs In Greatest Demand: Financials, Healthcare/Biotech; India's Signs of Life
- Most Overbought and Oversold ETFs
- A Biotech Bloom in July
- Biotech Buying Binge About to Begin?
- Monday Options Outlook: SGP, MRK, AZN, AMGN, CELG, BBH, BAC, KRE, XLF
- Portfolio Review: Biotech, Utilities Help Maintain Defensive Posture
- ETF Update: Utilities, Retail, Biotech and Agriculture
- Key ETFs Most Overbought and Oversold
- Biotech Fundamentals Still Look Strong
- ETF Update: HOLDRs, Leveraged ETFs,
- Biotech ETFs: Volatility, Technicals Pointing to a Recovery?
- Time for Biotech To Turn Around?
- ETF Fund Flows (Week Ending 3/14/08)
- Pharma, Biotech Present Great Investment Opportunities in 2008
- Investing in Biotech ETFs
- Thursday's Options Report: Biogen, Lehman, Citi, WM, BBH
- Homebuilders Lead Market Higher
- 30 ETFs With the Highest Short Interest Ratios
- Three Reasons To Turn To Biotech In A Messy Market
- ETF Update: Shorting Small Caps, New ETCs, Not All Sector ETFs Are Created Equal, Emerging Market Giants, ETF Review
- Bonds, Commodities Fare Best During This Pullback
- Profiting from the Cyclical Nature of Biotech Stocks
- Primary US Sector ETFs
- Homebuilder, Financial ETFs Currently Furthest Below Their 50-DMAs
- Many ETFs, Few Investment Opportunities: 127 Investable Funds
- 2 Biotech ETFs Differ Greatly in Constituents
- Continued Strength in Alternative Energy
- U.S. Group ETFs: Overbought/Oversold
- June ETF Short Interest Surges
- Sector Strength in Materials, Weakness in Biotech
- Strong Year for Biotech ETFs
- Healthcare, Pharma and Biotech ETFs
- Overbought/Oversold U.S. ETF Leaderboard
- The Day After: U.S. Overbought/Oversold ETFs
- Week-in-Review: Strength In Silver and Oil, While Biotech Slumps
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »